Interpace Biosciences, Inc. (IDXG)
OTCMKTS · Delayed Price · Currency is USD
6.60
+0.40 (6.45%)
Nov 11, 2026, 9:30 AM EST
Interpace Biosciences Earnings Call Transcripts
Fiscal Year 2026
-
The meeting approved all seven proposals, including board declassification, a reverse stock split, and new equity plans. Strategic priorities include launching a new pancreatic cancer test, expanding the product portfolio, and investing in research and lab automation.